ERS International Congress, Milan 2017

---

Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up

Thematic Poster
Chairs: A. Rich (Nottingham, United Kingdom), D. Behera (Chandigarh (U.T.), India), M. Glatzer (St. Gallen, Switzerland), D. Bumbacea (Bucarest, Romania)

Chemopreventive effect of long-term use of low-dose aspirin on lung cancer risk : A nationwide study considering competing risk E. Chun (Seoul, Republic of Korea)
Lung cancer in never smokers. An update of the Lung Cancer Risk Factors in Never Smokers Study (LCRINS) M. Torres Duran (Vigo (Pontevedra), Spain)
A comparison of patients with newly-diagnosed NSCLC between 3 metropolitan hospitals in Melbourne, Australia between 2012-2014. S. Karnam (Melbourne, Australia)
Trends in lung cancer in Eskisehir province of Turkey from January 1990 to December 2016. G. Ak (Eskisehir, Turkey)
Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study D. Jovanovic (Beograd, Republic of Serbia)
The dynamics of bronchoscopic results in lung cancer on a 10 year period.The experience of the Bronchology Department, Cluj-Napoca, Romania M. Simon (Cluj-Napoca/ Cluj, Romania)
Nsclc and egfr activating mutations (EGFRm+).  Experience from a reference center in Greece. S. Chrysikos (ATHENS, Greece)
Molecular and clinical profile of adenocarcinoma lung among Indian women P. Arjun (Trivandrum (Kerala), India)
Overall survival analysis and characterization of an EGFR mutated non small cell lung cancer (NSCLC) population F. Aguiar (Paredes, Portugal)
Croatian Caucasians with lung adenocarcinoma harbouring EGFR mutations with and without brain metastasis K. Sreter (Zagreb, Croatia)
Annual Southeast Asian haze affects lung cancer diagnosis and survival. T. Hassan (Dublin 8, Ireland)
Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival D. Mursic (Zagreb, Croatia)
Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer. P. Kuca (Otwock, Poland)
Clinical and Epidemiological Features of Lung Cancer Complicated with Pulmonary Embolism Y. Havlucu (Manisa, Turkey)
Lung cancer and HIV infection in a center M. Nobre Pereira (S. Brás de Alportel, Portugal)
Metastatic disease in non-small cell lung cancer: is it all the same? L. Meira (Leça da Palmeira, Portugal)
SCLC presenting as ovarian metastasis in a young pregnant. A case report. A. Cennamo (Pomigliano D'Arco, Italy)
Clinical Indicators of Survival in Stage IV Lung Cancer: Role of Metastases (M) Descriptor P. Zhu (Montréal, QC, Canada)
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT). N. Hansen (Odense C, Denmark)
Clinical factors of long-term survival in patients with advanced lung cancer K. Murase (Tokyo, Japan)